Zytoprotec Zytoprotec is a life science company that develops drugs using a cytoprotection therapeutic approach. | NeuClone NeuClone is a clinical-stage biopharmaceutical company that develops and commercializes biosimilar products. | ||
Founding Date | Founding Date 2022 | Founding Date 2007 | Founding Date 2007 |
Type | Type Private | Type Private | Type Private |
Tags | |||
Locations | Locations Plymouth, US HQ | Locations Wien, AT HQ | Locations Eveleigh, AU HQ |
Employees | Employees 405% increase | Employees N/A | Employees 9 |
Funding | |||
Total funding raised | Total funding raised $ 122m | Total funding raised $ 2.7m | Total funding raised N/A |
Zytoprotec is a life science company that develops drugs using a cytoprotection therapeutic approach.
View companyNeuClone is a clinical-stage biopharmaceutical company that develops and commercializes biosimilar products.
View company